Euroapi Company Header Euroapi Company Header

X

Find Andiamine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)
79
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

0

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Andiamine
Also known as: Andiamine, 50-62-4, Reoxyl, Ustimon, P60cs4tihv, Flussicor
Molecular Formula
C30H46Cl2N2O10
Molecular Weight
665.6  g/mol
InChI Key
GIOKUMNZQFCEPI-UHFFFAOYSA-N
FDA UNII
P60CS4TIHV

A potent vasoactive agent that dilates cerebral and coronary arteries, but slightly constricts femoral arteries, without any effects on heart rate, blood pressure or cardiac output.
1 2D Structure

Andiamine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-[methyl-[2-[methyl-[3-(3,4,5-trimethoxybenzoyl)oxypropyl]amino]ethyl]amino]propyl 3,4,5-trimethoxybenzoate;dihydrochloride
2.1.2 InChI
InChI=1S/C30H44N2O10.2ClH/c1-31(11-9-15-41-29(33)21-17-23(35-3)27(39-7)24(18-21)36-4)13-14-32(2)12-10-16-42-30(34)22-19-25(37-5)28(40-8)26(20-22)38-6;;/h17-20H,9-16H2,1-8H3;2*1H
2.1.3 InChI Key
GIOKUMNZQFCEPI-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN(CCCOC(=O)C1=CC(=C(C(=C1)OC)OC)OC)CCN(C)CCCOC(=O)C2=CC(=C(C(=C2)OC)OC)OC.Cl.Cl
2.2 Other Identifiers
2.2.1 UNII
P60CS4TIHV
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Andiamine

2. Ditrimine

3. Hexobendine

4. Ustimon

2.3.2 Depositor-Supplied Synonyms

1. Andiamine

2. 50-62-4

3. Reoxyl

4. Ustimon

5. P60cs4tihv

6. Flussicor

7. 3-[methyl-[2-[methyl-[3-(3,4,5-trimethoxybenzoyl)oxypropyl]amino]ethyl]amino]propyl 3,4,5-trimethoxybenzoate;dihydrochloride

8. Hexobendine Hcl

9. (ethane-1,2-diylbis(methylazanediyl))bis(propane-3,1-diyl) Bis(3,4,5-trimethoxybenzoate) Dihydrochloride

10. 3-[methyl-[2-[methyl-[3-(3,4,5-trimethoxybenzoyl)oxypropyl]amino]ethyl]amino]propyl3,4,5-trimethoxybenzoate Dihydrochloride

11. Einecs 200-054-7

12. Unii-p60cs4tihv

13. Hexobendine Hydrochloride

14. Hexobendine Dihy-drochloride

15. Benzoic Acid, 3,4,5-trimethoxy-, 1,2-ethanediylbis((methylimino)-3,1-propanediyl) Ester, 2hcl

16. N,n'-dimethyl-n,n'-bis(3-(3',4',5'-trimethoxybenzoxy)propyl)ethylenediamine Dihydrochloride

17. Schembl317378

18. Dtxsid90964485

19. St-7090

20. Hexobendine Dihydrochloride [mi]

21. Benzoic Acid, 3,4,5-trimethoxy-, Diester With 3,3'-(ethylenebis(methylimino))di-1-propanol, Dihydrochloride

22. Hexobendine Hydrochloride [who-dd]

23. Ft-0669197

24. Q27286267

25. (ethane-1,2-diyl)bis[(methylazanediyl)propane-3,1-diyl] Bis(3,4,5-trimethoxybenzoate)--hydrogen Chloride (1/2)

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 665.6 g/mol
Molecular Formula C30H46Cl2N2O10
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count12
Rotatable Bond Count21
Exact Mass664.2529511 g/mol
Monoisotopic Mass664.2529511 g/mol
Topological Polar Surface Area115 Ų
Heavy Atom Count44
Formal Charge0
Complexity684
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Vasodilator Agents

Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY